// App-Quantinova.ai

OP0199 : POINTS TO CONSIDER WHEN ANALYSING AND REPORTING COMPARATIVE EFFECTIVENESS RESEARCH WITH OBSERVATIONAL DATA IN RHEUMATOLOGY

Researchers

Presenter

  • D. Courvoisier

Principal Investigators

  • K. Lauper

  • S. A. Bergstra

  • M. De Wit

  • B. Fautrel

  • T. Frisell

  • K. Hyrich

  • F. Iannone

  • J. Kedra

  • P. M. Machado

  • L. Midtbll rnbjerg

  • Z. Rotar

  • M. J. Santos

  • T. Stamm

  • S. Stones

  • A. Strangfeld

  • R. B. M. Landew

  • A. Finckh

Medical Centers

  • Geneva University Hospitals, Geneva, Switzerland

  • LUMC, Radiology, Leiden, Netherlands

  • EULAR Patient Research Partner, Amsterdam, Netherlands

  • Pitié-Salpêtrière Hospital, APHP, Rheumatology, Paris, France

  • Karolinska Institutet, Clinical Epidemiology Unit, Stockholm, Sweden

  • The University of Manchester, Centre for Epidemiology Versus Arthritis, M13 9PT, United Kingdom

  • University Hospital of Bari, GISEA, Rheumatology, Bari, Italy

  • Institut Pierre Louis dEpidemiologie et de Sante Publique, INSERM UMR_S 1136, Paris, France

  • University College London, Centre for Rheumatology Research & MRC Centre for Neuromuscular Diseases, London, United Kingdom

  • Rigshospitalet Glostrup, Centre for Rheumatology and Spinal Diseases, Copenhagen, Denmark

  • University Medical Centre Ljubljana, Department of Rheumatology, Ljubljana, Slovenia

  • Faculdade Medicina de Lisboa, Rheumatology, Lisboa, Portugal

  • Medical University of Vienna, Center for Medical Statistics, Informatics and Intelligent Systems, Vienna, Austria

  • EULAR Patient Research Partner, London, United Kingdom

  • Deutsches Rheuma-Forschungszentrum, Programmbereich Epidemiologie, Berlin, Germany

  • Zuyderland Medical Centre Heerlen, Rheumatology, Limburg, Netherlands

  • Amsterdam University Medical Center - Amsterdam - Netherlands (The)

Locations

  • Switzerland

  • Netherlands

  • France

  • Sweden

  • United Kingdom

  • Italy

  • Denmark

  • Slovenia

  • Portugal

  • Austria

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved